Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Stampanoni Bassi

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Genes|February 25, 2022
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple SclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019
Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.
Journal of Neuroinflammation|May 14, 2024
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosisLivia Guadalupi, Valentina Vanni, Sara Balletta, et al.
Genes|May 28, 2022
Interleukin 6 SNP <i>rs1818879</i> Regulates Radiological and Inflammatory Activity in Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
International Journal of Molecular Sciences|August 29, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple SclerosisEttore Dolcetti, Fabio Buttari, Antonio Bruno, et al.
International Journal of Molecular Sciences|May 25, 2024
Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.
Current Neuropharmacology|April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.
Frontiers in Molecular Neuroscience|August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Immunology|June 24, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosisKrizia Sanna, Antonio Bruno, Sara Balletta, et al.
Neurobiology of Disease|July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Genes|February 25, 2022
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple SclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019
Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.
Journal of Neuroinflammation|May 14, 2024
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosisLivia Guadalupi, Valentina Vanni, Sara Balletta, et al.
Genes|May 28, 2022
Interleukin 6 SNP <i>rs1818879</i> Regulates Radiological and Inflammatory Activity in Multiple SclerosisAntonio Bruno, Ettore Dolcetti, Federica Azzolini, et al.
International Journal of Molecular Sciences|August 29, 2024
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple SclerosisEttore Dolcetti, Fabio Buttari, Antonio Bruno, et al.
International Journal of Molecular Sciences|May 25, 2024
Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.
Current Neuropharmacology|April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.
Frontiers in Molecular Neuroscience|August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Immunology|June 24, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosisKrizia Sanna, Antonio Bruno, Sara Balletta, et al.
Neurobiology of Disease|July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Pageof 9